A randomised controlled trial to evaluate the impact of SMARTphone and Internet assisted self-management and adherence tools to manage Parkinson?s Disease (PD): the SMART-PD trial

uMotif Limited (UK)0 个研究点目标入组 266 人开始时间: 2013年11月5日最近更新: 2018年11月12日

适应症

试验速览

•1. Adults aged 21-75 years or over diagnosed with, or with probable, idiopathic PD
•2. Prescribed one or more anti-parkinsonian medications by a consultant neurologist or consultant physician or GP with specialist knowledge of movement disorders
•3. English speaking and literate i.e can read, write, and speak in English and compute and solve problems at levels of proficiency necessary to function daily at job and/or daily living
•4. Has access to a smartphone and/or internet on a regular (> weekly) basis in their home
•5. Stable medication regime i.e. not altered within the previous month and not expected to change during the period of the trial (16 weeks)
•6. Not diagnosed with dementia or significant cognitive impairment

•1. Suspected Parkinsonism due to other causes than idiopathic PD
•2. Treated with anti-parkinsonian medications (anti-cholinergics) for side effects of prolonged neuroleptic treatment
•3. Diagnosed with dementia or significant cognitive impairment
•4. Diagnosed with mental illness associated with psychosis ? schizophrenia, severe depression with psychosis, bipolar affective disorder
•5. Detrimental illness with a short life expectancy

发起方

uMotif Limited (UK)